All presentations from the AACR Annual Meeting 2019 are now available free to everyone.

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

Presentations Access:

clear all | select all

Presentation Access:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Vascular-Immune Cell Crosstalk: Implications for Cancer Immunotherapy

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5
Vascular-Immune Cell Crosstalk: Implications for Cancer Immunotherapy
Chairperson
Gabriele Bergers
VIB-Center of Cancer Biology, Leuven, Belgium
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Vascular-Immune Cell Crosstalk: Implications for Cancer Immunotherapy
  •  
  • Permission not
    granted for presentation
  •  
  •  
Improving immunotherapy of cancer by normalizing tumor vessels
Rakesh K Jain
Harvard Medical School, Boston, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Vascular-Immune Cell Crosstalk: Implications for Cancer Immunotherapy
Inducing high-endothelial venules in cancer to improve immunotherapy
Gabriele Bergers
VIB-Center of Cancer Biology, Leuven, Belgium
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Vascular-Immune Cell Crosstalk: Implications for Cancer Immunotherapy
  •  
  • Permission not
    granted for presentation
  •  
  •  
Targeting the tumor microenvironment for treatment of chemo-resistant desmoplastic colon cancer
Tatiana Petrova
University of Lausanne, Lausanne, Switzerland
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
Vascular-Immune Cell Crosstalk: Implications for Cancer Immunotherapy
  •  
  • Free
  • Unknown permission
    for presentation
  •  
  •  
Clinical development of anti-angiogenic and immune checkpoint blockade combinations
F Stephen Hodi
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on March 30, 2019 8:00 AM-10:00 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5